My Linh Kha is Senior Vice President and Regional General Manager, JAPAC. She was appointed as Vice President & General Manager, Japan Asia-Pacific (JAPAC) in November 2020. Until July 2021, she was also Vice President and General Manager of Amgen China. Prior to returning to Amgen Australia as the General Manager in 2016, My Linh spent more than two years as Executive Director Marketing for Amgen’s Intercontinental Region (Latin America, Canada, Turkey, Middle East & Africa).
Ms. Kha has had more than 20 years of broad international experience in both emerging and mature markets in the biopharmaceutical industry. Ms. Kha’s expertise includes business start-ups, turn around and transformations. She has deep knowledge of brand and organization strategy, healthcare regulatory policy and product pricing. She has a track record of delivering performances beating market expectations.
Ms. Kha began her career with Amgen in early 2011 when she joined Amgen Australia as the Business Unit Director for General Medicine, with responsibility for the Bone, Nephrology and Cardiology therapeutic areas.
Before joining Amgen, Ms. Kha spent more than a decade at Merck (MSD) taking various leadership roles of increasing responsibility, including Marketing Lead (New Zealand), Managing Director (Vietnam), and Head of Commercial Operations (Korea).
Ms. Kha’s career started in the building and construction industry where she worked in business development and management consulting.
Ms. Kha holds a Bachelor of Science degree and a Bachelor of Law degree from University of Canterbury, New Zealand.
